MADRONE CAPITAL PARTNERS LLC 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:48 pm Purchase |
2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB |
MADRONE CAPITAL PARTNERS LLC | 26,891,915 9.900% |
5,800,000 (+27.50%) |
Filing |
| 2024-02-13 4:15 pm Purchase |
2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
MADRONE CAPITAL PARTNERS LLC | 21,091,915 7.900% |
1,175,982 (+5.90%) |
Filing |
| 2023-02-13 4:03 pm Purchase |
2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
MADRONE CAPITAL PARTNERS LLC | 19,915,933 8.800% |
3,000,000 (+17.73%) |
Filing |
| 2022-06-01 4:00 pm Purchase |
2022-03-15 | 13G | Pacific Biosciences of California, Inc. PACB |
MADRONE CAPITAL PARTNERS LLC | 16,915,933 7.500% |
16,915,933 (New Position) |
Filing |